Skip to main content
Idexx Laboratories10-Q: Product launch

IDEXX inVue Dx Analyzer Placements Drive 32.7% Diagnostics Instrument Revenue Growth

Source: Autobound Signal API · 59 signals tracked for Idexx Laboratories · updated

Get Idexx Laboratories' live signals in Claude or ChatGPT, or by API

AskWhat changed at Idexx Laboratories this week? Use Autobound signals for idexx.com.

What happened

CAG Diagnostics capital instrument revenue increased 32.7% to $42.449 million primarily due to placements of the IDEXX inVue Dx Analyzer compared to a controlled launch in Q1 2025.

Source

Extracted by Autobound

From the Signal API record
Signal
10-Q: Product launch

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Mar 31, 2026
Fiscal year end
03/31
Filed
May 5, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Percent
32.7% (CAG Diagnostics capital - instruments revenue reported growth)

Details

CIK
874716
Accession number
0000874716-26-000076
Timeframe
Current quarter
Quarter
Q1
Filing year
2026
Period end date
Mar 31, 2026
Why it matters
Go-to-market support
Signal category
Strategic

Topics and mentions

Technologies

  • IDEXX inVue DxTM Analyzer

Extraction

Confidence
High
Relevance
75%
Sentiment
Positive
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
productLaunch

Use this data

Get every 10-Q signal for Idexx Laboratories and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Idexx Laboratories this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/2c18cd57-446e-46a4-b8a3-cd7b8f8b946a returns this record as JSON. POST /v1/companies/enrich returns every signal for idexx.com.

{
  "signal_id": "2c18cd57-446e-46a4-b8a3-cd7b8f8b946a",
  "signal_type": "sec-10q",
  "signal_subtype": "productLaunch",
  "detected_at": "2026-11-09T06:27:09.138+00:00",
  "company": {
    "name": "Idexx Laboratories",
    "domain": "idexx.com"
  },
  "data": {
    "detail": "CAG Diagnostics capital instrument revenue increased 32.7% to $42.449 million primarily due to placements of the IDEXX inVue Dx Analyzer compared to a controlled launch in Q1 2025. This expansion of novel point-of-care instruments may create opportunities for vendors providing diagnostic components, laboratory software integrations, and related manufacturing support.",
    "metrics": {
      "pct": 0.327,
      "timeframe": "current_quarter",
      "pct_context": "CAG Diagnostics capital - instruments revenue reported growth",
      "dollar_context": "CAG Diagnostics capital - instruments revenue"
    },
    "quarter": "Q1",
    "summary": "IDEXX inVue Dx Analyzer Placements Drive 32.7% Diagnostics Instrument Revenue Growth",
    "excerpts": "Instrument revenue gains were primarily due to placements of our IDEXX inVue DxTM Analyzer, compared to the first quarter of 2025 when we continued a controlled launch.",
    "relevance": 0.75,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/874716/000087471626000076/idxx-20260331.htm",
    "filing_date": "2026-05-05",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "03/31",
    "period_end_date": "2026-03-31",
    "sales_relevance": "Go-to-market support",
    "signal_category": "strategic",
    "technologies_mentioned": [
      "IDEXX inVue DxTM Analyzer"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.